Digital therapeutics are no longer a futuristic concept; they’re actively transforming how patients receive, monitor, and manage care. As the MedTech industry evolves, DTx solutions have become central to personalized, preventive, and data-driven healthcare. At Innominds, we work with leading global MedTech innovators to design and engineer next-generation digital therapeutic platforms that

As healthcare devices become more intelligent and more connected, Edge AI is emerging as a transformative force across the MedTech landscape. Edge AI brings intelligence directly to the device, enabling medical systems to analyze data locally, make real-time decisions, and operate effectively even without continuous cloud connectivity. For device manufacturers, this shift represents more than a

The healthcare industry is undergoing a profound shift — moving beyond episodic treatment toward continuous, intelligent, and empathetic patient journeys. As Digital Therapeutics (DTx) evolve into data-driven care ecosystems, Generative AI (Gen AI) is redefining how patients experience therapy, adhere to treatment, and achieve meaningful health outcomes.

Digital health is entering a new era — one where Generative AI (GenAI) drives deeper and more human-centered patient engagement. As Digital Therapeutics (DTx) redefine care delivery through evidence-based software interventions, their success increasingly depends on one factor — sustained patient engagement and adherence. That’s where GenAI transforms the equation — making digital health

The construction industry is at a tipping point. Large projects are becoming increasingly complex, labor shortages are intensifying, and pressure to deliver on time and within budget has never been higher. Studies show that more than 70% of large construction projects exceed timelines and costs, while safety incidents and compliance lapses continue to challenge even the best-run firms.

Digital Therapeutics (DTx) are revolutionizing the way patients manage chronic conditions, mental health disorders, and lifestyle diseases. Yet, while most DTx solutions succeed in creating awareness, few manage to sustain adherence — the true measure of both clinical and commercial success.

In regulated industries like MedTech, compliance is non-negotiable. It safeguards patient safety, data integrity, and market trust. But here’s the hidden truth: the very systems designed to protect innovation are often slowing it down.

For decades, clinical excellence was the gold standard in healthcare. Superior diagnostics, expert physicians, and breakthrough treatments defined the patient experience. But in today’s consumer-driven landscape, clinical excellence alone is no longer enough. Patients don’t just want to be treated—they want to be seen, heard, understood, and empowered.

Clinical laboratories are rapidly evolving from traditional testing centres into strategic enablers of personalized medicine. This transformation is powered by advanced data pipelines, real-time analytics, and generative AI (Gen AI), which together enable faster, more accurate, and regulation-aligned operations. As diagnostic complexity grows and compliance demands intensify, smart labs are

In preclinical research, where speed and accuracy are paramount, scientists often find themselves buried in vast volumes of scientific literature, internal reports, and experimental data. The effort to process all this information—while staying compliant and current—can slow down decision-making at a time when speed matters most. That’s where Generative AI (GenAI), and Large Language Models